Mergers in micro-cap land are rarely a fairy tale.
Passage Bio ($PASG) announced its merger with Remix Therapeutics and was immediately rewarded with a -19.22% drop. When small caps merge, the market usually smells dilution, not synergy.
Contrast that with Autozi ($AZI) climbing +40.35% on a securities purchase agreement. The crowd rushes in, but the historical baseline for catalyst-driven gap-ups of this size shows a median intraday return of -6.79%, closing red 65% of the time.
Shut down the monitors and review your journal.